Moreover, ATP13A2 mutations were also reported in neuronal ceroid lipofuscinosis (NCL)9, amyotrophic lateral sclerosis (ALS)10, and hereditary spastic paraplegia (HSP)11. The gene discussed is ATP13A2; the disease is neuronal ceroid lipofuscinosis.